Are Rossari Biotech latest results good or bad?
Rossari Biotech's latest results are positive, with net sales reaching Rs 579.56 crore and a consolidated net profit of Rs 34.44 crore, both marking significant improvements. The company shows a consistent growth trend, although monitoring non-operating income will be important for future stability.
Rossari Biotech has reported its financial results for the quarter ending March 2025, showcasing notable operational trends. The company achieved net sales of Rs 579.56 crore, which represents the highest quarterly sales in the last five quarters, indicating a consistent growth trajectory. Additionally, the operating profit before depreciation, interest, and taxes (PBDIT) reached Rs 69.49 crore, also marking a peak for the same period, suggesting a positive trend in operational performance.The consolidated net profit for the quarter was Rs 34.44 crore, reflecting an upward movement compared to the previous quarter. Furthermore, the company's non-operating income rose to Rs 1.79 crore, the highest in the last five quarters, which may prompt considerations regarding the sustainability of this income source moving forward.
Overall, Rossari Biotech's financial performance has shown improvement, accompanied by an adjustment in its evaluation over the past three months. The data indicates a positive operational trend, with growth in both sales and profit metrics, while also highlighting the importance of monitoring non-operating income for future stability.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
